| Left Ventricular Hypertrophy Among Chronic Kidney Disease Patients in Assiut University Hospital (NCT05002010) | Assiut University | 2022-02-01 |
| Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy. (NCT04929600) | Shanghai Jiao Tong University School of Medicine | 2021-11-28 |
| Postnatal Steroids Effects on Cardiac Function in Extremely Preterm (NCT04644094) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-06-15 |
| Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) (NCT04752293) | Wake Forest University Health Sciences | 2021-05-19 |
| Empagliflozin and Cardiac Remodelling in People Without Diabetes (NCT04461041) | Unity Health Toronto | 2021-04-01 |
| Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy (NCT04275882) | Cardiovascular Academy Society, Turkey | 2020-02-14 |
| Protective Monocytes and Macrophages to Limit Decompensation and Heart Damaging (NCT04022330) | Assistance Publique - Hôpitaux de Paris | 2019-10-15 |
| FGF23 and Angiotensin-(1-7) in Hypophosphatemia (GAP) (NCT03489993) | Wake Forest University Health Sciences | 2018-12-06 |
| Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease (NCT03666351) | Hanmi Pharmaceutical Company Limited | 2018-10-18 |
| Imaging Histone Deacetylase in the Heart (NCT03549559) | Massachusetts General Hospital | 2018-09-07 |
| Mechanism of Decompensation Evaluation - Aortic Stenosis (NCT03332745) | University of Edinburgh | 2018-09-03 |
| Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient (NCT03193073) | Omnia Mohammed Hashem | 2018-09-01 |
| The Use of Blood Biochemical Markers for Diagnostics of Heart Muscle Diseases (NCT05726695) | University Hospital Ostrava | 2018-06-01 |
| Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients (NCT03182699) | Rainer Oberbauer | 2017-10-01 |
| Diffusion MRI in Heart Failure (NCT02973633) | Massachusetts General Hospital | 2017-06-30 |
| Does Dapagliflozin Regress Left Ventricular Hypertrophy In Patients With Type 2 Diabetes? (NCT02956811) | University of Dundee | 2017-02-14 |
| MRI Sequence and Imaging Protocol Development (NCT03040947) | National Heart Centre Singapore | 2016-03-01 |
| Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease. (NCT03759002) | Isfahan University of Medical Sciences | 2016-02-01 |
| Response of the Myocardium to Hypertrophic Conditions in the Adult Population (NCT02670031) | National Heart Centre Singapore | 2016-01-01 |
| Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study (NCT02493465) | Instituto de Urologia e Nefrologia | 2015-07-01 |
| MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease (NCT02226510) | University of Dundee | 2015-03-01 |
| ReNEW Clinic Cohort Study (NCT03816462) | Johns Hopkins University | 2015-01-01 |
| In-Centre Nocturnal Hemodialysis (INHD): A Long-Term Follow-Up Study (NCT02684773) | Unity Health Toronto | 2014-07-01 |
| Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy (NCT03186742) | Poznan University of Medical Sciences | 2014-07-01 |
| Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography (NCT02221141) | Laurence Gabriel | 2013-12-01 |
| Frequency of Cardiac Amyloidosis in the Caribbean's. (TEAM Amylose) (NCT03322319) | University Hospital Center of Martinique | 2013-09-23 |
| Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study (NCT01951404) | University of Dundee | 2013-09-01 |
| Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome (NCT02295176) | Rottapharm | 2013-04-01 |
| Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG (NCT03219632) | Seoul National University Bundang Hospital | 2012-06-05 |
| Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients (NCT01360476) | Wayne State University | 2011-08-01 |
| Serum Sclerostin Levels, Cardiovascular Parameters and Carpal Tunnel Syndrome in Maintenance Hemodialysis Patients (NCT01382966) | RFM Renal Treatment Services | 2011-07-01 |
| Impact of Physical Activity on Left Ventricular Mass and Lipid Metabolism (NCT01199211) | University of California, San Francisco | 2011-02-01 |
| The Effect of Heart Rate on Cardiac Index in Patients With Left Ventricular Hypertrophy (NCT01241838) | University of Aarhus | 2011-02-01 |
| The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients (NCT01455974) | Capital Medical University | 2010-10-01 |
| Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy (NCT01188369) | University of Aarhus | 2010-09-01 |
| Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy (NCT01198899) | University Hospital, Ghent | 2009-07-01 |
| Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension (NCT01442116) | Mustafa Kemal University | 2009-06-01 |
| Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (NCT00985322) | Mario Negri Institute for Pharmacological Research | 2009-05-01 |
| Viennese Prevalence Study of Anderson-Fabry Disease (NCT00871611) | Medical University of Vienna | 2009-01-01 |
| Impact of In-centre Nocturnal Hemodialysis on Ventricular Remodeling and Function in End-stage Renal Disease (NCT00718848) | Unity Health Toronto | 2008-07-01 |
| The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4 (NCT00497146) | AbbVie (prior sponsor, Abbott) | 2008-02-01 |
| Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort (NCT00344903) | University of Texas Southwestern Medical Center | 2007-09-01 |
| Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH (NCT00607633) | AstraZeneca | 2007-01-01 |
| Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy (NCT01425411) | Mustafa Kemal University | 2006-11-01 |
| Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan (NCT00602004) | Melbourne Health | 2006-10-01 |
| Chronic Heart Failure Analysis and Registry in the Tohoku District 2 (CHART-2 Study) (NCT00418041) | Hiroaki Shimokawa, MD, PhD | 2006-10-01 |
| Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) (NCT00348686) | AstraZeneca | 2006-06-01 |
| Stenting of Renal Artery Stenosis in Coronary Artery Disease Study (NCT01173666) | Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele | 2006-04-01 |
| Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis (NCT00294775) | Odense University Hospital | 2006-02-01 |
| Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension (NCT00219141) | Novartis Pharmaceuticals | 2005-10-01 |
| Hypertension in Hemodialysis Patients (Aim 3) (NCT00582114) | Indiana University | 2005-08-01 |
| Value of Cardiac Magnetic Resonance (CMR) Derived Parameters for Diagnosing Left Ventricular Non-compaction Cardiomyopathy (NCT01481298) | University of Leipzig | 2004-12-01 |
| Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension (NCT00139555) | Novartis | 2004-07-01 |
| Pulse Wave Analysis and Velocity in Patients With Chronic Renal Failure: a Cross-sectional Observational Study to Assess Association With Left Ventricular Hypertrophy, Uremic Toxins and Inflammation. (NCT01579032) | Universitaire Ziekenhuizen KU Leuven | 2004-01-01 |
| Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression (NCT00518479) | University of Leeds | 2003-09-01 |
| Hypertension in Hemodialysis (NCT00067665) | Indiana University | 2003-08-01 |
| Access Creation for Hemodialysis: Association With Structural Changes of the Heart (NCT00368147) | Ottawa Hospital Research Institute | 2002-04-01 |
| Active Vitamin D Effect on Left Ventricular Hypertrophy (NCT00175149) | Per Ivarsen | 2002-01-01 |
| Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts (NCT00001878) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-02-01 |
| A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. (NCT00364260) | Janssen-Ortho Inc., Canada | 1997-12-01 |
| Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease (NCT00001632) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-09-01 |
| Long Term Effects of Enalapril and Losartan on Genetic Heart Disease (NCT00001534) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Stress Reduction in the Prevention of Left Ventricular Hypertrophy (NCT05373732) | Maharishi International University | 1996-04-01 |